Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|
Operating Income | ($185.8M) | ($183.2M) | ($92.7M) | ($637.0M) | ($370.9M) | ($208.5M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Clover Health Investments, Corp.'s last 12-month Operating Income is ($90.0M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Clover Health Investments, Corp.'s Operating Income growth was (64.0%). The average annual Operating Income growth rates for Clover Health Investments, Corp. have been (21.4%) over the past three years, (5.5%) over the past five years.
Over the last year, Clover Health Investments, Corp.'s Operating Income growth was (64.0%), which is lower than industry growth of (0.1%). It indicates that Clover Health Investments, Corp.'s Operating Income growth is Bad.